COST-EFFECTIVENESS OF THE PNEUMOCOCCAL CONJUGATE VACCINE 10 VERSUS 13 ON PNEUMOCOCCAL DISEASE IN CHILDREN IN SWEDEN

被引：0
|
作者：
Peeters, E. [1 ]
Marijam, A. [2 ]
Chevalier, P. [1 ]
Ene, J. [3 ]
Folkesson, J. [3 ]
Izurieta, P. [2 ]
Joost, S. [4 ]
Urbonas, G. [5 ]
Adbelghany, M. [6 ]
机构：
[1] IQVIA, Zaventem, Belgium
[2] GSK, Wavre, Belgium
[3] IQVIA, Solna, Sweden
[4] GSK, Amersfoort, UT, Netherlands
[5] GSK, Warsaw, Poland
[6] GSK, Cairo, Egypt
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE166
引用
收藏
页码：S85 / S85
页数：1
相关论文
共 50 条
  • [1] Cost-Effectiveness of a 10-Versus 13-Valent Pneumococcal Conjugate Vaccine in Denmark and Sweden
    Klok, Rogier M.
    Lindkvist, Rose-Marie
    Ekelund, Mats
    Farkouh, Raymond A.
    Strutton, David R.
    CLINICAL THERAPEUTICS, 2013, 35 (02) : 119 - 134
  • [2] Cost-effectiveness of the 13-valent Pneumococcal Conjugate Vaccine in Children in Portugal
    Gouveia, Miguel
    Fiorentino, Francesca
    Jesus, Goncalo
    Costa, Joao
    Borges, Margarida
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2017, 36 (08) : 782 - 787
  • [3] COST-EFFECTIVENESS OF SWITCHING FROM THE 10-VALENT TO THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN SWEDEN
    Wasserman, M.
    Dorange, A. C.
    Palmborg, A.
    McDade, C.
    Wilson, M.
    Horn, E.
    VALUE IN HEALTH, 2022, 25 (01) : S110 - S110
  • [4] Cost-effectiveness of pneumococcal conjugate vaccine analyzed
    不详
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2000, 57 (09) : 840 - 840
  • [5] Cost-effectiveness of 13-valent pneumococcal conjugate vaccine in Switzerland
    Blank, Patricia R.
    Szucs, Thomas D.
    VACCINE, 2012, 30 (28) : 4267 - 4275
  • [6] Cost-effectiveness of pneumococcal conjugate vaccines of 7, 10, and 13 valences in Colombian children
    Castaneda-Orjuela, Carlos
    Alvis-Guzman, Nelson
    Velandia-Gonzalez, Martha
    De la Hoz-Restrepo, Fernando
    VACCINE, 2012, 30 (11) : 1936 - 1943
  • [7] THE COST-EFFECTIVENESS OF THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN CHINESE CITIES
    Furnback, W.
    Wang, B. C. M.
    Zhu, S.
    Dong, P.
    VALUE IN HEALTH, 2020, 23 : S170 - S170
  • [8] COST-EFFECTIVENESS OF THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN ADULTS IN PORTUGAL
    Alarcao, J.
    Fiorentino, F.
    Gouveia, M.
    Jesus, G.
    Costa, J.
    Borges, M.
    VALUE IN HEALTH, 2016, 19 (07) : A414 - A414
  • [9] Cost-effectiveness of a national immunization program with the 13-valent pneumococcal conjugate vaccine compared with the 10-valent pneumococcal conjugate vaccine in South Korea
    Kim, Hye-Young
    Park, Seong-Beom
    Kang, Eun-Sil
    Lee, Sang-Min
    Kim, Hyun-Jin
    Wasserman, Matt
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (03) : 909 - 918
  • [10] Comparison of the Impact of Pneumococcal Conjugate Vaccine 10 or Pneumococcal Conjugate Vaccine 13 on Invasive Pneumococcal Disease in Equivalent Populations
    Naucler
    CLINICAL INFECTIOUS DISEASES, 2019, 68 (03) : 534 - 534
12345